These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34418487)

  • 21. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
    Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
    Moorman CD; Bastian AG; DeOca KB; Mannie MD
    J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.
    Pardo E; Cárcamo C; Uribe-San Martín R; Ciampi E; Segovia-Miranda F; Curkovic-Peña C; Montecino F; Holmes C; Tichauer JE; Acuña E; Osorio-Barrios F; Castro M; Cortes P; Oyanadel C; Valenzuela DM; Pacheco R; Naves R; Soza A; González A
    PLoS One; 2017; 12(6):e0177472. PubMed ID: 28650992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
    Pakravan N; Ghaffarinia A; Parvaneh S; Yaslianifard S; Jalili C; Riazi-Rad F
    Neurol Res; 2016 Feb; 38(2):103-9. PubMed ID: 27118606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
    Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
    J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulated follicular regulatory T cells and antibody responses exacerbate experimental autoimmune encephalomyelitis.
    Luo L; Hu X; Dixon ML; Pope BJ; Leavenworth JD; Raman C; Meador WR; Leavenworth JW
    J Neuroinflammation; 2021 Jan; 18(1):27. PubMed ID: 33468194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells.
    O'Connor RA; Malpass KH; Anderton SM
    J Immunol; 2007 Jul; 179(2):958-66. PubMed ID: 17617587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Puberty in females enhances the risk of an outcome of multiple sclerosis in children and the development of central nervous system autoimmunity in mice.
    Ahn JJ; O'Mahony J; Moshkova M; Hanwell HE; Singh H; Zhang MA; Marrie RA; Bar-Or A; Sadovnick DA; Dunn SE; Banwell BL
    Mult Scler; 2015 May; 21(6):735-48. PubMed ID: 25533291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
    Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):545-67. PubMed ID: 21284556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T cells in multiple sclerosis and myasthenia gravis.
    Danikowski KM; Jayaraman S; Prabhakar BS
    J Neuroinflammation; 2017 Jun; 14(1):117. PubMed ID: 28599652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
    Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
    J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children.
    Horellou P; de Chalus A; Giorgi L; Leroy C; Chrétien P; Hacein-Bey-Abina S; Bourgeois C; Mariette X; Serguera C; Le Grand R; Deiva K
    Front Immunol; 2021; 12():679770. PubMed ID: 34220827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells.
    Ronin E; Pouchy C; Khosravi M; Hilaire M; Grégoire S; Casrouge A; Kassem S; Sleurs D; Martin GH; Chanson N; Lombardi Y; Lalle G; Wajant H; Auffray C; Lucas B; Marodon G; Grinberg-Bleyer Y; Salomon BL
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33766913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
    Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
    Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.